Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries GeneDx to Participate in Fall Investor Conferences By: GeneDx via Business Wire August 12, 2024 at 16:05 PM EDT GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences this fall: UBS Genomic Medicine Summit – August 13-14, 2024 Dana Point, California Future of Genetic Testing - Babies and Beyond Panel on Wednesday, August 14 at 8:00 a.m. PT Morgan Stanley Healthcare Conference - September 4-6, 2024 New York, New York Wells Fargo Healthcare Conference - September 4-6, 2024 Boston, Massachusetts Fireside chat on Thursday, September 5 at 8:45 a.m. ET Jefferies London Healthcare Conference - November 19-21, 2024 London, England Live and archived webcasts of select presentations will be available on the “Events” section of the GeneDx investor relations website at ir.genedx.com/news-events/events. About GeneDx At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It all starts with a single test. For more information, please visit genedx.com and connect with us on LinkedIn, X, Facebook, and Instagram. View source version on businesswire.com: https://www.businesswire.com/news/home/20240812959337/en/Contacts Investor Relations Contact: investors@GeneDx.com Media Contact: press@GeneDx.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
GeneDx to Participate in Fall Investor Conferences By: GeneDx via Business Wire August 12, 2024 at 16:05 PM EDT GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences this fall: UBS Genomic Medicine Summit – August 13-14, 2024 Dana Point, California Future of Genetic Testing - Babies and Beyond Panel on Wednesday, August 14 at 8:00 a.m. PT Morgan Stanley Healthcare Conference - September 4-6, 2024 New York, New York Wells Fargo Healthcare Conference - September 4-6, 2024 Boston, Massachusetts Fireside chat on Thursday, September 5 at 8:45 a.m. ET Jefferies London Healthcare Conference - November 19-21, 2024 London, England Live and archived webcasts of select presentations will be available on the “Events” section of the GeneDx investor relations website at ir.genedx.com/news-events/events. About GeneDx At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It all starts with a single test. For more information, please visit genedx.com and connect with us on LinkedIn, X, Facebook, and Instagram. View source version on businesswire.com: https://www.businesswire.com/news/home/20240812959337/en/Contacts Investor Relations Contact: investors@GeneDx.com Media Contact: press@GeneDx.com
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences this fall: UBS Genomic Medicine Summit – August 13-14, 2024 Dana Point, California Future of Genetic Testing - Babies and Beyond Panel on Wednesday, August 14 at 8:00 a.m. PT Morgan Stanley Healthcare Conference - September 4-6, 2024 New York, New York Wells Fargo Healthcare Conference - September 4-6, 2024 Boston, Massachusetts Fireside chat on Thursday, September 5 at 8:45 a.m. ET Jefferies London Healthcare Conference - November 19-21, 2024 London, England Live and archived webcasts of select presentations will be available on the “Events” section of the GeneDx investor relations website at ir.genedx.com/news-events/events. About GeneDx At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It all starts with a single test. For more information, please visit genedx.com and connect with us on LinkedIn, X, Facebook, and Instagram. View source version on businesswire.com: https://www.businesswire.com/news/home/20240812959337/en/
